QR Kod

Patient preferences for treatments in hormone receptor-positive/HER2-negative metastatic breast cancer in Italy: a discrete choice experiment study

Abstract Hormone receptor (HR) positive (HR +) and human epidermal growth factor receptor 2 (HER2) negative (aka HER2 −) breast cancer (BC) is the most frequently diagnosed subtype. Recent development of next-generation endocrine therapies (e.g. selective estrogen receptor degraders (SERDs); third-g...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Grazia Arpino, Carmine De Angelis, Lorenzo Gerratana, Matteo Lambertini, Sarah Igidbashian, Rosanna Gramigna, Xavier Guillaume
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2025-05-01
Seri Bilgileri:BMC Cancer
Konular:
Adverse events
Metastatic HR positive/HER2 negative breast cancer
Stakeholder preferences
Treatment administration
Treatment choice
Online Erişim:https://doi.org/10.1186/s12885-025-14308-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller